Development and Validation of a New Diabetes Risk Score in Guyana.

Community screening Diabetes mellitus Risk score Sensitivity and specificity Validation

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 03 01 2020
pubmed: 20 2 2020
medline: 20 2 2020
entrez: 20 2 2020
Statut: ppublish

Résumé

We present a new diabetes risk score developed and validated in a multi-ethnic population in Guyana, South America. Measurement of in-country diabetes prevalence is a vital epidemiologic tool to combat the pandemic. It is believed that for every person diagnosed with type 2 diabetes there is another undiagnosed. The International Diabetes Federation (IDF) recommends a two-step detection programme using a risk score questionnaire to identify high-risk individuals followed by glycaemic measure. Data on 798 persons from the 2016 STEPwise Approach to Chronic Disease Risk Factor Surveillance (STEPS) were used to correlate responses to 36 questions with glycated haemoglobin (HbA1C) and fasting plasma glucose (FPG) results. Bootstrapping was used to internally validate the derived seven-variable model. This model with the addition of family history questions was tested in a convenience sample of 659 Guyanese adults and externally validated in a cohort of another 528. An 8-item Guyana Diabetes Risk Score (GDRS) was derived. The final model performed with an area under the curve (AUC) of 0.812 CONCLUSIONS: The validated eight-item Guyana Diabetes Risk Score will be extremely useful in identifying individuals at high risk of having diabetes in Caribbean, Black or East Indian populations.

Identifiants

pubmed: 32072429
doi: 10.1007/s13300-020-00775-4
pii: 10.1007/s13300-020-00775-4
pmc: PMC7136361
doi:

Types de publication

Journal Article

Langues

eng

Pagination

873-883

Subventions

Organisme : Medical Research Council
ID : MR/R022739/1
Pays : United Kingdom
Organisme : Banting and Best Diabetes Centre, University of Toronto
ID : 14-862
Organisme : Medical Research Council
ID : MR/N015959/1
Pays : United Kingdom
Organisme : Banting and Best Diabetes Centre, University of Toronto
ID : 499334
Organisme : WDF
ID : 14-862

Références

Herman WH, Ye W, Griffin SJ, Simmons RK, Davies MJ, Khunti K, Rutten GE, Sandbaek A, Lauritzen T, Borch-Johnsen K, Brown MB, Wareham NJ. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe). Diabetes Care. 2015;38(8):1449–555.
doi: 10.2337/dc14-2459
Global Guideline for Type 2 Diabetes, International Diabetes Federation, Brussels, 2012.
IDF Atlas. 8th Edn. 2015. https://www.diabetesatlas.org/key-messages.html
Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S, DETECT-2 Collaboration. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care. 2006;29(2):410–4.
doi: 10.2337/diacare.29.02.06.dc05-0945
Carrillo-Larco RM, Aparcana-Granda DJ, Mejia JR, Barengo NC, Bernabe-Ortiz A. Risk scores for type 2 diabetes mellitus in Latin America: a systematic review of population-based studies. Diabet Med 2019;36:1573–84.
doi: 10.1111/dme.14114
Ke C, Persaud S, Singh K, Ostrow B, Lebovic G, Hincapié C, Lowe J. Prevalence of diabetes and pre-diabetes in Guyana: a Nationally Representative Study. 14th Jan 2020 Submitted to Diabetes Care
Implementation plan STEPwise Approach to Chronic Disease risk factor surveillance (STEPS), Ministry of Public Health, Guyana, 2015.
Collins GS, et al. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011;9:103.
doi: 10.1186/1741-7015-9-103
Caribbean Public Health Association. New trial to target preventable deaths in the Caribbean [Internet]. Jamaica. https://carpha.org/articles/ID/135/New-trial-to-target-preventable-deaths-in-the-Caribbean . Accessed 17 Feb 2017.
Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simulat Comput. 2009;38(6):1228–344.
doi: 10.1080/03610910902859574
Sullivan, Lisa M, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631–1660.
Harrell FE Jr (2018). RMS: regression modeling strategies. R package version 5.1-2. https://CRAN.R-project.org/package=rms .
"2012 Census Compendium 2". Statisticsguyana.gov.gy. Accessed 24 Sept 2019.
Tirimacco R, et al. Should capillary blood glucose measurements be used in population surveys? IJDM. 2010;2(1):24–7.
NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015, 3(8):624–37.
Krishnadath ISK, Nahar-van Venrooij LM, Jaddoe VWV, et al. Ethnic differences in prediabetes and diabetes in the Suriname Health Study. BMJ Open Diabetes Res Care. 2016;4:e000186. https://doi.org/10.1136/bmjdrc-2015-000186 .
doi: 10.1136/bmjdrc-2015-000186 pubmed: 27403324 pmcid: 4932318
Jindal RM, Soni R, Mehta K. TG patel incidence of diabetes and hypertension in indigenous Amerindian village in Guyana. S Am Indian J Nephrol. 2016;26:389–90.
doi: 10.4103/0971-4065.181471
Schulz LO, Bennett PH, Ravussin E, et al. Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the US. Diabetes Care. 2006;29:1866–71. https://doi.org/10.2337/dc06-0138 .
doi: 10.2337/dc06-0138 pubmed: 16873794

Auteurs

Julia Lowe (J)

Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Toronto, Canada. Julia.Lowe@newcastle.edu.au.

Calvin Ke (C)

Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Toronto, Canada.

Kavita Singh (K)

Chronic Diseases Unit, Ministry of Public Health, Lot 1 Brickdam St., Georgetown, Guyana.

Reeta Gobin (R)

Master of Public Health Programme, University of Guyana, Turkeyan Campus, Georgetown, Guyana.

Gerald Lebovic (G)

Applied Health Research Centre, St. Michael's Hospital, Toronto, Canada.

Brian Ostrow (B)

Department of Surgery, University of Toronto, Toronto, Canada.

Classifications MeSH